Soft tissue sarcoma (STS) is one of the most frequent second primary cancer that occurs
during the first 20 years following treatment for a solid cancer in childhood. Our aim was to …

BACKGROUND Previous studies have shown that children who are treated for soft tissue
sarcoma (STS) are at increased risk for developing second cancers. However, the risk for …

Abstract Among 16 541 3-year survivors of childhood cancer in Britain, 39 soft tissue
sarcomas (STSs) occurred and 1.1 sarcomas were expected, yielding a standardised …

PURPOSE: Childhood cancer survivors have an increased risk of secondary sarcomas. To
better identify those at risk, the relationship between therapeutic dose of chemotherapy and …

Osteosarcoma is the most frequent second primary cancer occurring during the first 20 years
following treatment for a solid cancer in childhood. Using a cohort study of children treated …

BACKGROUND Survivors of childhood malignancies have an increased risk of developing
second malignant neoplasms (SMN) due to their prior treatment and/or genetic …

Bone sarcoma as a second malignancy is rare but highly fatal. The present knowledge
about radiation-absorbed organ dose–response is insufficient to predict the risks induced by …

A hospital-based case-control study on soft tissue sarcomas (STS) was conducted in 1983-
84 in Torino and in Padova (Italy). Cases (36 children with rhabdomyosarcoma (RMS) and …

Soft-tissue sarcomas (STS) have been associated with various rare cancer syndromes and
occur at increased frequencies in survivors of childhood cancer. Also adult patients with STS …

Of a cohort of 634 children treated from 1942 to 1969 at the Gustave Roussy Institute for a
first cancer and alive 5 years after treatment, 32 later developed second malignant …